Skip to main content
. 2008 Dec 15;58(4):926–933. doi: 10.2337/db08-0900

TABLE 2.

Baseline characteristics of people with type 2 diabetes of the Casale Monferrato Study, by living status on 31 December 2006

Survived Deceased P
n 1,885 496
Men 922 (48.9) 262 (52.8) 0.12
Age (years) 65.9 ± 10.2 74.1 ± 8.5 <0.0001
Duration of diabetes (years) 10.2 ± 7.8 12.6 ± 8.4 <0.0001
CRP (mg/dl) 2.5 (1.2–5.3) 3.7 (1.6–9.1) <0.0001
    <1.6 642 (34.1) 117 (23.6) <0.0001
    1.6–4.4 671 (35.6) 163 (32.8)
    >4.4 572 (30.3) 216 (43.6)
BMI (kg/m2) 28.9 ± 5.0 28.0 ± 5.4 0.0009
Waist circumference (cm) 98.2 ± 12.2 98.3 ± 12.8 0.82
Systolic blood pressure (mmHg) 145.5 ± 16.2 146.7 ± 17.1 0.14
Diastolic blood pressure (mmHg) 83.0 ± 8.2 82.3 ± 8.4 0.10
Hypertension 1,653 (87.9) 458 (92.3) 0.005
Glucose (mg/dl) 171.5 ± 53.5 178.3 ± 60.0 0.014
A1C (%) 7.0 ± 1.7 7.3 ± 1.9 0.0003
Total cholesterol (mg/dl) 213.1 ± 40.0 206.3 ± 40.2 0.001
LDL cholesterol (mg/dl) 129.0 ± 34.2 122.3 ± 33.9 0.0002
HDL cholesterol (mg/dl) 54.7 ± 14.8 55.0 ± 16.6 0.70
Triglycerides (mg/dl) 129.6 (92–177) 127.7 (87–175) 0.57
ApoA1 (mg/dl) 154.9 ± 38.8 150.7 ± 39.1 0.03
ApoB (mg/dl) 102.8 ± 26.3 100.0 ± 28.3 0.04
ApoB/apoA1 0.72 ± 0.33 0.72 ± 0.34 0.99
Creatinine (mg/dl) 0.83 (0.69–0.97) 0.93 (0.73–1.11) <0.001
Fibrinogen (g/l) 372.1 ± 68.5 406.9 ± 110.4 <0.0001
Uric acid (mg/dl) 5.52 ± 1.73 6.04 ± 2.51 <0.0001
AER (μg/min) 12.1 (4.2–25.5) 21.3 (6.4–49.3) <0.0001
    20–200 377 (24.3) 113 (35.3)
    >200 73 (4.7) 28 (8.8)
CVD 353 (18.7) 157 (31.6) 0.0001
Smoking
    Former smoker 534 (29.3) 166 (34.9) 0.03
    Smoker 291 (16.0) 60 (12.6)
Glucose-lowering treatment
    Diet 303 (71.0) 62 (12.7) <0.0001
    Oral drugs 1,402 (75.4) 337 (68.9)
    Insulin 155 (8.3) 90 (18.4)
Statins 379 (20.1) 98 (19.8) 0.98

Data are means ± SD, n (%), or geometric means (95% CI).